MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djag226

Медицинская библиотека · Journal of the National Cancer Institute · 2026

Epigenetic aging during adjuvant chemotherapy for colon cancer and modification by a resistance training intervention.

Binder Alexandra M, Weltzien Erin, Cespedes Feliciano Elizabeth M, Brown Justin C, Lee Catherine, Ross Michelle, Campbell Kristin L, Castillo Adrienne, Pena Perez Amalia, Meyerhardt Jeffrey A, Schmitz Kathryn H, Caan Bette J

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cancer survivors experience excess morbidity and functional decline compared with age-matched individuals without cancer, potentially reflecting acceleration of biological aging during cancer treatment. Epigenetic clocks derived from DNA methylation (DNAm) quantify biological aging, but whether changes in these measures during chemotherapy are modifiable remains unclear.

METHODS

We evaluated longitudinal changes in epigenetic age acceleration among adults with stage II-III colon cancer undergoing adjuvant chemotherapy in the FORCE randomized trial. Participants were assigned to usual care or resistance training during chemotherapy. Blood DNAm was assessed at baseline and follow-up to derive multiple clocks, including DNAmPhenoAge, GrimAge, and DunedinPACE acceleration measures. Body composition and physical function were measured longitudinally. Linear mixed-effects models estimated changes in epigenetic age acceleration and intervention effects.

RESULTS

DunedinPACE acceleration showed the largest increase during treatment (0.70 SD per 6 months, 95% CI: 0.41, 0.98), followed by GrimAge acceleration (0.29 SD per 6 months, 95% CI: 0.13, 0.46; approximately 1.2 years). At baseline, higher DunedinPACE acceleration was associated with greater adiposity and poorer physical function. Resistance training attenuated increases in GrimAge acceleration: usual care participants showed significant acceleration (0.45 SD per 6 months, 95% CI: 0.24, 0.60), whereas intervention participants did not. Changes in epigenetic age acceleration were not strongly associated with body composition or physical function changes.

CONCLUSIONS

Epigenetic age acceleration increased during colon cancer treatment, with resistance training attenuating GrimAge acceleration. These intervention-responsive changes suggest DNAm-based aging measures may capture treatment-period physiologic changes not fully reflected by body composition or physical function.

Для цитирования: Binder Alexandra M, Weltzien Erin, Cespedes Feliciano Elizabeth M, Brown Justin C, Lee Catherine, Ross Michelle, Campbell Kristin L, Castillo Adrienne, Pena Perez Amalia, Meyerhardt Jeffrey A, Schmitz Kathryn H, Caan Bette J. Epigenetic aging during adjuvant chemotherapy for colon cancer and modification by a resistance training intervention.. Journal of the National Cancer Institute. 2026. DOI: 10.1093/jnci/djag226.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.